{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:40:50Z","timestamp":1778172050640,"version":"3.51.4"},"reference-count":34,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"abstract":"\n CONTEXT:<\/jats:title>\n Treatment options for allergic asthma include allergen avoidance, pharmacotherapy, and allergen immunotherapy.<\/jats:p>\n <\/jats:sec>\n \n OBJECTIVES:<\/jats:title>\n Summarize and update current evidence for the efficacy and safety of subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) in pediatric allergic asthma.<\/jats:p>\n <\/jats:sec>\n \n DATA SOURCES:<\/jats:title>\n PubMed, Embase, Cochrane Central Register of Controlled Trials (January 1, 2005, through May 8, 2017), ClinicalTrials.gov, and the US Food and Drug Administration Adverse Event Reporting System. We reevaluated trials from our 2013 systematic review.<\/jats:p>\n <\/jats:sec>\n \n STUDY SELECTION:<\/jats:title>\n We included studies with children \u226418 years of age in which researchers reported on prespecified outcomes and had an intervention arm receiving aeroallergen SCIT or SLIT. Only randomized controlled trials (RCTs) were included for efficacy. RCTs and non-RCTs were included for safety outcomes.<\/jats:p>\n <\/jats:sec>\n \n DATA EXTRACTION:<\/jats:title>\n Two reviewers extracted data. We included 40 studies (17 SCIT trials, 11 SLIT trials, 8 non-RCTs for SCIT safety, and 4 non-RCTs for SLIT safety).<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n We found moderate-strength evidence that SCIT reduces long-term asthma medication use. We found low-strength evidence that SCIT improves asthma-related quality of life and forced expiratory volume in 1 second. There was also low-strength evidence that SLIT improves medication use and forced expiratory volume in 1 second. There was insufficient evidence on asthma symptoms and health care use.<\/jats:p>\n <\/jats:sec>\n \n LIMITATIONS:<\/jats:title>\n There were no trials in which researchers evaluated asthma symptoms using a validated tool. Study characteristics and outcomes were reported heterogeneously.<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS:<\/jats:title>\n In children with allergic asthma, SCIT may reduce long-term asthma medication use. Local and systemic allergic reactions are common, but anaphylaxis is reported rarely.<\/jats:p>\n <\/jats:sec>","DOI":"10.1542\/peds.2017-3833","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T07:30:17Z","timestamp":1521790217000},"source":"Crossref","is-referenced-by-count":68,"title":["Allergen-Specific Immunotherapy in the Treatment of Pediatric Asthma: A Systematic Review"],"prefix":"10.1542","volume":"141","author":[{"given":"Jessica L.","family":"Rice","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Pediatric Pulmonology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory B.","family":"Diette","sequence":"additional","affiliation":[{"name":"Department of Medicine, Pulmonary and Critical Care Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalina","family":"Suarez-Cuervo","sequence":"additional","affiliation":[{"name":"Evidence-based Practice Center, Department of Health Policy and Management, Johns Hopkins School of Public Health, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily P.","family":"Brigham","sequence":"additional","affiliation":[{"name":"Department of Medicine, Pulmonary and Critical Care Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra Y.","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Murugappan","family":"Ramanathan","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen A.","family":"Robinson","sequence":"additional","affiliation":[{"name":"General Internal Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Azar","sequence":"additional","affiliation":[{"name":"Allergy and Clinical Immunology,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2018,5,1]]},"reference":[{"key":"2021121018361626300_B1","volume-title":"Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma","author":"National Asthma Education and Prevention Program, Third Expert Panel on the Diagnosis and Management of Asthma","year":"2007"},{"key":"2021121018361626300_B2","unstructured":"Centers for Disease Control and Prevention. Most recent asthma data. 2015. Available at: www.cdc.gov\/asthma\/most_recent_data.htm. Accessed August 25, 2017"},{"issue":"5","key":"2021121018361626300_B3","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaci.2007.07.056","article-title":"Asthma cases attributable to atopy: results from the Third National Health and Nutrition Examination Survey.","volume":"120","author":"Arbes","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2021121018361626300_B4","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jaci.2013.01.049","article-title":"Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology\/European Academy of Allergy and Clinical Immunology\/PRACTALL consensus report.","volume":"131","author":"Burks","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"2021121018361626300_B5","unstructured":"US Food and Drug Administration. Allergen extract sublingual tablets. 2014. Available at: www.fda.gov\/BiologicsBloodVaccines\/Allergenics\/ucm391505.htm. Accessed May 20, 2014"},{"key":"2021121018361626300_B6","volume-title":"Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and\/or Asthma: Comparative Effectiveness Review","author":"Lin","year":"2013"},{"key":"2021121018361626300_B7","doi-asserted-by":"crossref","DOI":"10.23970\/AHRQEPCCER196","volume-title":"The Role of Immunotherapy in the Treatment of Asthma. Comparative Effectiveness Review No. 196","author":"Lin","year":"2017"},{"issue":"8","key":"2021121018361626300_B8","first-page":"CD001186","article-title":"Injection allergen immunotherapy for asthma.","author":"Abramson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"2021121018361626300_B9","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1398-9995.2006.01205.x","article-title":"Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method.","volume":"61","author":"Calamita","year":"2006","journal-title":"Allergy"},{"issue":"5","key":"2021121018361626300_B10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/all.13104","article-title":"Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review.","volume":"72","author":"Di Bona","year":"2017","journal-title":"Allergy"},{"key":"2021121018361626300_B11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update.","volume":"127","author":"Cox","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2021121018361626300_B12","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2011"},{"key":"2021121018361626300_B13","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"9237","key":"2021121018361626300_B14","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management.","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"2021121018361626300_B15","volume-title":"Methods Guide for Effectiveness and Comparative Effectiveness Reviews","author":"Agency for Healthcare Research and Quality","year":"2014"},{"issue":"11","key":"2021121018361626300_B16","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jclinepi.2014.11.023","article-title":"Grading the strength of a body of evidence when assessing health care interventions: an EPC update.","volume":"68","author":"Berkman","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"2021121018361626300_B17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/all.12278","article-title":"Vitamin D as an adjunct to subcutaneous allergen immunotherapy in asthmatic children sensitized to house dust mite.","volume":"69","author":"Baris","year":"2014","journal-title":"Allergy"},{"issue":"3","key":"2021121018361626300_B18","first-page":"285","article-title":"Evaluation of efficacy of immunotherapy in children with asthma monosensitized to Alternaria.","volume":"53","author":"Kili\u00e7","year":"2011","journal-title":"Turk J Pediatr"},{"issue":"2","key":"2021121018361626300_B19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000368832","article-title":"Assessing the efficacy of immunotherapy with a glutaraldehyde-modified house dust mite extract in children by monitoring changes in clinical parameters and inflammatory markers in exhaled breath.","volume":"165","author":"Lozano","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"2021121018361626300_B20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3892\/etm.2014.1469","article-title":"Efficacy analysis of three-year subcutaneous SQ-standardized specific immunotherapy in house dust mite-allergic children with asthma.","volume":"7","author":"Hui","year":"2014","journal-title":"Exp Ther Med"},{"issue":"5","key":"2021121018361626300_B21","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1056\/NEJM199701303360502","article-title":"A controlled trial of immunotherapy for asthma in allergic children.","volume":"336","author":"Adkinson","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"2021121018361626300_B22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1875-9572(10)60004-6","article-title":"Clinical efficacy of house dust mite-specific immunotherapy in asthmatic children.","volume":"51","author":"Tsai","year":"2010","journal-title":"Pediatr Neonatol"},{"issue":"9","key":"2021121018361626300_B23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1034\/j.1398-9995.2002.23498.x","article-title":"Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study.","volume":"57","author":"Pifferi","year":"2002","journal-title":"Allergy"},{"issue":"4","key":"2021121018361626300_B24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2500\/aap.2010.31.3353","article-title":"Efficacy of immunotherapy for treatment of allergic asthma in children.","volume":"31","author":"Alzakar","year":"2010","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"2021121018361626300_B25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1399-3038.2006.00475.x","article-title":"Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.","volume":"18","author":"Pham-Thi","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"2021121018361626300_B26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ppul.1088","article-title":"Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study.","volume":"32","author":"Bah\u00e7eciler","year":"2001","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"2021121018361626300_B27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2222.2008.03159.x","article-title":"Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.","volume":"39","author":"Stelmach","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"2021121018361626300_B28","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1399-3038.2006.00443.x","article-title":"Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.","volume":"17","author":"Lue","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"issue":"8","key":"2021121018361626300_B29","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.rmed.2005.11.016","article-title":"Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.","volume":"100","author":"Niu","year":"2006","journal-title":"Respir Med"},{"issue":"3","key":"2021121018361626300_B30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1034\/j.1399-3038.2003.00025.x","article-title":"Immunomodulation during sublingual therapy in allergic children.","volume":"14","author":"Ippoliti","year":"2003","journal-title":"Pediatr Allergy Immunol"},{"key":"2021121018361626300_B31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.11604\/pamj.2013.14.155.1891","article-title":"Allergen specific immunotherapy induced multi-organ failure.","volume":"14","author":"Sana","year":"2013","journal-title":"Pan Afr Med J"},{"issue":"3","key":"2021121018361626300_B32","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1398-9995.2007.01563.x","article-title":"Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose.","volume":"63","author":"Blazowski","year":"2008","journal-title":"Allergy"},{"issue":"6","key":"2021121018361626300_B33","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1542\/peds.2013-0343","article-title":"Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review.","volume":"131","author":"Kim","year":"2013","journal-title":"Pediatrics"},{"issue":"1","key":"2021121018361626300_B34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaip.2014.06.023","article-title":"Allergist-reported trends in the practice of food allergen oral immunotherapy.","volume":"3","author":"Greenhawt","year":"2015","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2017-3833\/1065841\/peds_20173833.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2017-3833\/1065841\/peds_20173833.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T05:28:29Z","timestamp":1639200509000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/141\/5\/e20173833\/37897\/Allergen-Specific-Immunotherapy-in-the-Treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,1]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2017-3833","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,1]]},"article-number":"e20173833"}}